Why The Biotech Boom Is Still In The 1st Inning
Joe explains why he believes the biotech boom still has plenty of legs, and Leigh and Joe discuss how to value pharmaceutical stocks.
The discussion covers specific names including Gilead Sciences, Inc. (NASDAQ: GILD), BioDelivery Sciences International, Inc. (NASDAQ: BDSI), Retrophin Inc (NASDAQ: RTRX) and Auspex Pharmaceuticals Inc (NASDAQ: ASPX).
Image credit: Jeffrey Beall, Wikimedia
The following article is from one of our external contributors. It does not represent the opinion of Benzinga and has not been edited.